Skip to main content
SpringerLink
Log in

Some questions concerning the value of psychotherapy in nonhospitalized patients treated with psychopharmacologic agents

  • Published:
Psychiatric Quarterly Aims and scope Submit manuscript

Summary

The author questions the rationale for the use of psychotherapy in drug-treated patients. On the basis of clinical and theoretical considerations, he expresses the opinion that psychopharmacotherapy alone can be effective in neuroses and some psychoses and also suggests that psychotherapy is indicated only in the treatment of patients with well-defined personality disorders. Problems concerning the management and discharge of drug-treated individuals are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Zilboorg, G.: Ambulatory treatment of schizophrenia. Synopsis, Lectures to the Second International Congress of Psychiatry. Zurich. 1957.

  2. Sarwer-Foner, G. J.: Psycho-analytic theories of activity-passivity conflicts and the continuum of ego defenses. Arch. Neurol. and Psychiat., 78:413, 1957.

    Article  CAS  Google Scholar 

  3. Sarwer-Foner, G. J., and Ogle, W.: Progress in Neurology & Psychiatry. Vol. X, p. 431. Grune & Stratton. New York. 1957.

    Google Scholar 

  4. Bourne, H.: Psychotherapy and tranquilizers. New Zealand Med. J., 56:392, 1957. (Abst., Dig. Neurol. and Psychiat., Hartford, Conn., December 1957.)

    CAS  PubMed  Google Scholar 

  5. Szasz, T. S.: Some observations on the use of tranquilizing drugs. In: Gordon, H. L.: The New Chemotherapy in Mental Illness. P. 100. Philosophical Library. New York. 1958.

    Google Scholar 

  6. Kris, E. B., and Carmichael, D. M.: Follow-up study on thorazine-treated patients. Am. J. Psychiat., 114:449, 1957.

    Article  CAS  PubMed  Google Scholar 

  7. Kline, N. S., and Saunders, J. C.: Reserpine in psychiatric and neurologic disorder. Med. Clin. No. Am., 307, 1957.

  8. Freyhan, F. A.: Clinical effectiveness of tofranil in the treatment of depressive psychoses. Canad. Psychiat. Asso. J. (Special Suppl.), 4:S86, 1959.

    Google Scholar 

  9. Hoch, P. H.: Practical and theoretical applications of new drug therapies in psychiatry. Arch. Neurol. and Psychiat., 75:325, 1956.

    Article  Google Scholar 

  10. : Progress in psychiatric therapies. In: Gordon, H. L.: The New Chemotherapy in Mental Illness. P. 82. Philosophical Library. New York. 1958.

    Google Scholar 

  11. : Psychodynamics and psychotherapy of depressions. Canad. Psychiat. Asso. J. (Special Suppl.), 4:S24, 1959.

    Google Scholar 

  12. Bowes, H. A.: The ataractic drugs: the present position of chlorpromazine, frenquel, pacatal, and resorpine in the psychiatric hospital. Am. J. Psychiat., 113: 530, 1956.

    Article  Google Scholar 

  13. Kinross-Wright, V.: Chlorpromazine in psychiatric disorders. Med. Clin. No. Am., 296, 1957.

  14. Payn, S. B., and Rockwell, F. V.: Short treatment of psychiatric patients with reserpine. N. Y. S. J. Med., 56:1769, 1956.

    CAS  Google Scholar 

  15. Silverberg, W. V., and Clovis Hirning, L.: Psychotherapy and adjunctive means in psychiatry. Am. J. Psychother., 12:760, 1958.

    CAS  PubMed  Google Scholar 

  16. Hoff, H.: Indications for electroshock and psychotherapy in the treatment of depressions. Canad. Psychiat. Asso. J. (Special Suppl.), 4:S55, 1959.

    Google Scholar 

  17. Rothman, T., and Sward, K.: Studies in pharmacologic psychotherapy: effective psychotherapy during drug-induced states. Arch. Neurol. and Psychiat., 78:628, 1957.

    Article  CAS  Google Scholar 

  18. Feldman, P. E.: Quoted by Kline. In: Progress in Neurology and Psychiatry. Vol. XI, P. 444. Grune & Stratton. New York. 1958.

    Google Scholar 

  19. Azima, H.: Psychodynamic alterations concomitant with tofranil administration. Canad Psychiat. Asso. J. (Special Suppl.), 4:S172, 1959.

    Google Scholar 

  20. Lesse, S.: Psychotherapy and ataraxics: some observations on combined psychotherapy and chlorpromazine therapy. Am. J. Psychother., 10:448, 1956.

    CAS  PubMed  Google Scholar 

  21. Lesse, S.: Psychodynamic relationship between the degree of anxiety and other clinical symptoms. J. N. M. D., 127:124, 1958.

    CAS  Google Scholar 

  22. Winkelman, N. W.: An appraisal of chlorpromazine. Am. J. Psychiat., 113:961, 1957.

    Article  PubMed  Google Scholar 

  23. Stevenson, G.: Quoted by Kline. In: Progress in Neurology and Psychiatry. Vol. XI. P. 441. Grune & Stratton. New York. 1958.

    Google Scholar 

  24. Ferguson, R. S.: A clinical trial of reserpine in the treatment of anxiety. J. Ment. Sci., 102:30, 1956.

    CAS  PubMed  Google Scholar 

  25. Wolberg, L. R.: The Technique of Psychotherapy. P. 4. Grune & Stratton. New York. 1954.

    Google Scholar 

  26. Heath, R. G.; Leach, B. E.; Byers, L. W.; Martens, S., and Feigley, C. A.: Pharmacological and bioloical psychotherapy. Am. J. Psychiat., 114:683, 1957.

    Article  Google Scholar 

  27. Roth, M.: The phenomenology of depressive states. Canad. Psychiat. Asso. J. (Special Suppl.), 4:S32, 1959.

    Google Scholar 

  28. Fabing, H. D.: The ataractic drugs: their uses and limitations in psychiatry. In: Gordon, H. L.: The New Chemotherapy in Mental Illness. P. 36. Philosophical Library. New York. 1958.

    Google Scholar 

  29. Barsa, J. A.: The dual action of tranquilizers. Am. J. Psychiat., 114:74, 1957.

    Article  CAS  PubMed  Google Scholar 

  30. Kety, S. S.: Biochemical theories of schizophrenia. Science, 129: (Part I) 1528, (Part II) 1590, 1959.

    Article  CAS  PubMed  Google Scholar 

  31. Fink, M.: A unified theory of action of physiodynamic therapies. J. Hillside Hosp., 6:197, 1957.

    Google Scholar 

  32. Himwich, H. E.: Psychopharmacologic drugs. Science, 127:59, 1958.

    Article  CAS  PubMed  Google Scholar 

  33. Cleghorn, R. A.: Research Highlights. P. 195. U. S. Department of Health Education and Welfare, N.I.H., Washington, D. C. 1958.

    Google Scholar 

  34. Crane, G. E.: Clinical and pharmacological studies of marsilid and theoretical considerations concerning its anti-depressant action. J. N. M. D., 127:238, 1959.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 685 West End Avenue (Apt. 10E), New York 25, N. Y.

    George E. Crane M.D.

Authors
  1. George E. Crane M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This paper from Montefiore Hospital, the Bronx, N. Y. was read at the American Psychiatric Association divisional meeting, November 27–29, 1959, New York, N. Y.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Crane, G.E. Some questions concerning the value of psychotherapy in nonhospitalized patients treated with psychopharmacologic agents. Psych Quar 34, 430–442 (1960). https://doi.org/10.1007/BF01562424

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01562424

Keywords

Search

Navigation